WALL STREET ASSOCIATES - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 105 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q1 2016$288,000
-86.0%
274,600
-60.6%
0.12%
-79.2%
Q4 2015$2,054,000
-6.6%
696,3000.0%0.58%
+37.3%
Q3 2015$2,200,000
-69.4%
696,300
-42.7%
0.42%
-37.9%
Q2 2015$7,195,000
-45.6%
1,215,400
-1.7%
0.68%
-45.7%
Q1 2015$13,224,000
+11.8%
1,237,000
-1.8%
1.25%
+10.1%
Q4 2014$11,827,000
+32.6%
1,259,500
+8.4%
1.13%
+23.1%
Q3 2014$8,922,000
-18.9%
1,161,700
-5.2%
0.92%
-2.5%
Q2 2014$11,000,0001,225,0000.94%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,484,649$7,330,0008.59%
Avoro Capital Advisors LLC 5,144,916$15,178,0005.23%
Broadfin Capital, LLC 6,090,829$17,968,0001.10%
Aisling Capital LLC 2,010,000$5,930,0001.02%
Healthcare Value Capital, LLC 150,000$443,0000.73%
ACUTA CAPITAL PARTNERS, LLC 434,300$1,281,0000.61%
WALL STREET ASSOCIATES 696,300$2,054,0000.58%
SEARLE & CO. 172,500$500,0000.48%
Elk Creek Partners, LLC 2,253,667$6,648,0000.47%
KOPP INVESTMENT ADVISORS LLC 315,293$931,0000.46%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders